Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
0.540
Biomarker
disease
BEFREE
Variants in ZNHIT3 have not been identified in patients with PEHO or PEHO-like syndrome in other populations.
31048081
2020
Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
0.540
GeneticVariation
disease
BEFREE
In this study, we report a consanguineous Saudi family with a novel homozygous nonsense mutation of the CCDC88A gene causing PEHO-like syndrome .
30392057
2019
Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
0.540
Biomarker
disease
GENOMICS_ENGLAND
In this study, we report a consanguineous Saudi family with a novel homozygous nonsense mutation of the CCDC88A gene causing PEHO-like syndrome .
30392057
2019
Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
0.540
GermlineCausalMutation
disease
ORPHANET
CCDC88A mutations cause PEHO-like syndrome in humans and mouse.
26917597
2016
Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
0.540
GeneticVariation
disease
BEFREE
CCDC88A mutations cause PEHO-like syndrome in humans and mouse.
26917597
2016
Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
0.540
Biomarker
disease
GENOMICS_ENGLAND
CCDC88A mutations cause PEHO-like syndrome in humans and mouse.
26917597
2016
Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
0.540
Biomarker
disease
BEFREE
We suggest that PEHO or a PEHO-like syndrome may affect more patients than are currently identified, based on the original diagnostic criteria for this disorder.
12949965
2003
PEHO syndrome
0.320
GeneticVariation
disease
BEFREE
In conclusion, a complete loss of protein function due to premature stop gain was caused by a mutation in exon 12 of CCDC88A .This loss may lead to PEHO phenotype.
30392057
2019
PEHO syndrome
0.320
Biomarker
disease
BEFREE
As the mouse knockout phenotype mimics the human PEHO phenotype this suggests that loss of CCDC88A is a cause of the PEHO phenotype, and that CCDC88A is essential for multiple aspects of normal human neurodevelopment.
26917597
2016
PEHO syndrome
0.320
Biomarker
disease
GENOMICS_ENGLAND
As the mouse knockout phenotype mimics the human PEHO phenotype this suggests that loss of CCDC88A is a cause of the PEHO phenotype, and that CCDC88A is essential for multiple aspects of normal human neurodevelopment.
26917597
2016
Microcephaly
0.300
Biomarker
disease
GENOMICS_ENGLAND
A novel homozygous nonsense mutation in CCDC88A gene cause PEHO-like syndrome in consanguineous Saudi family.
30392057
2019
Body Height
0.100
GeneticVariation
phenotype
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
Body Height
0.100
GeneticVariation
phenotype
GWASCAT
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.
21998595
2011
Height
0.100
GeneticVariation
phenotype
GWASDB
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.
21998595
2011
×
CUI:
C0013604
Disease:
Edema
Edema
0.100
Biomarker
phenotype
HPO
Myoclonus
0.100
Biomarker
phenotype
HPO
Optic Atrophy
0.100
Biomarker
disease
HPO
Status Epilepticus
0.100
Biomarker
disease
HPO
Hyperreflexia
0.100
Biomarker
phenotype
HPO
Feeding difficulties
0.100
Biomarker
phenotype
HPO
Open mouth (finding)
0.100
Biomarker
phenotype
HPO
Polymicrogyria
0.100
Biomarker
disease
HPO
Pachygyria
0.100
Biomarker
disease
HPO
Hypoplasia of corpus callosum
0.100
Biomarker
disease
HPO
Global developmental delay
0.100
Biomarker
disease
HPO